VLON Insider Trading Activity and SEC Form 4 Filings
VLON insider trading summary
No open-market insider purchases or sales of Vallon Pharmaceuticals, Inc. (VLON) have been reported on SEC Form 4 in the past 12 months.
Latest VLON insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 4, 2021 | Leanne M. Kelly | Chief Financial Officer | Buy | $6K (1,508 @ $4.08) |
| Jun 3, 2021 | Leanne M. Kelly | Chief Financial Officer | Buy | $4K (1,085 @ $4.05) |
| Jun 2, 2021 | Leanne M. Kelly | Chief Financial Officer | Buy | $15K (3,657 @ $4.00) |
| May 26, 2021 | Joseph E Payne | Director | Buy | $31K (6,800 @ $4.50) |
| May 25, 2021 | Joseph E Payne | Director | Buy | $41K (10,700 @ $3.85) |
| Feb 12, 2021 | David Charles Baker | Chief Executive Officer | Buy | $8K (1,000 @ $8.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.